Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-2-5
pubmed:abstractText
In children, intermittent asthma is the most common pattern and is responsible for the majority of exacerbations. Montelukast has a rapid onset of action and may be effective if used intermittently.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1073-449X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
175
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
323-9
pubmed:dateRevised
2007-7-26
pubmed:meshHeading
pubmed-meshheading:17110643-Absenteeism, pubmed-meshheading:17110643-Acetates, pubmed-meshheading:17110643-Adolescent, pubmed-meshheading:17110643-Adrenergic beta-Agonists, pubmed-meshheading:17110643-Anti-Asthmatic Agents, pubmed-meshheading:17110643-Asthma, pubmed-meshheading:17110643-Child, pubmed-meshheading:17110643-Child, Preschool, pubmed-meshheading:17110643-Double-Blind Method, pubmed-meshheading:17110643-Drug Administration Schedule, pubmed-meshheading:17110643-Drug Utilization, pubmed-meshheading:17110643-Emergency Service, Hospital, pubmed-meshheading:17110643-Female, pubmed-meshheading:17110643-Glucocorticoids, pubmed-meshheading:17110643-Hospitalization, pubmed-meshheading:17110643-Humans, pubmed-meshheading:17110643-Male, pubmed-meshheading:17110643-Office Visits, pubmed-meshheading:17110643-Physicians, Family, pubmed-meshheading:17110643-Prednisolone, pubmed-meshheading:17110643-Quinolines, pubmed-meshheading:17110643-Severity of Illness Index, pubmed-meshheading:17110643-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
pubmed:affiliation
Department of Respiratory Medicine, Royal Children's Hospital, Parkville, Victoria, Australia. colin.robertson@rch.org.au
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study